RS20050420A - Prevencija i lečenje alzheimer-ove bolesti - Google Patents

Prevencija i lečenje alzheimer-ove bolesti

Info

Publication number: RS20050420A
Authority: RS; Serbia
Prior art keywords: inhibitor; disease; alzheimer; prevention; treatment
Prior art date: 2002-12-12

Application number

YUP-2005/0420A

Other languages

English (en)

Serbian (sr)

Inventor

Thierry Canton

Laurent Pradier

Jesus Benavides

Hubert HEUER

Hans Ludwig Schaefer

Original Assignee

Aventis Pharma S.A.,

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-12

Filing date

2003-12-10

Publication date

2007-04-10

2003-12-10 Application filed by Aventis Pharma S.A., filed Critical Aventis Pharma S.A.,

2007-04-10 Publication of RS20050420A publication Critical patent/RS20050420A/sr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

YUP-2005/0420A 2002-12-12 2003-12-10 Prevencija i lečenje alzheimer-ove bolesti RS20050420A (xx)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0215722A FR2848452B1 (fr)	2002-12-12	2002-12-12	Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
PCT/FR2003/003654 WO2004062652A1 (fr)	2002-12-12	2003-12-10	Application et traitement de la maladie d'alzheimer

Publications (1)

Publication Number	Publication Date
RS20050420A true RS20050420A (xx)	2007-04-10

Family

ID=32338722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
YUP-2005/0420A RS20050420A (xx)	2002-12-12	2003-12-10	Prevencija i lečenje alzheimer-ove bolesti

Country Status (22)

Country	Link
EP (1)	EP1572174A1 (xx)
JP (1)	JP2006514063A (xx)
KR (1)	KR20050084250A (xx)
CN (1)	CN1726016A (xx)
AR (1)	AR042354A1 (xx)
AU (1)	AU2003296802A1 (xx)
BR (1)	BR0317280A (xx)
CA (1)	CA2507945A1 (xx)
CO (1)	CO5700712A2 (xx)
FR (1)	FR2848452B1 (xx)
HR (1)	HRP20050534A2 (xx)
MA (1)	MA27500A1 (xx)
MX (1)	MXPA05005556A (xx)
NO (1)	NO20053341L (xx)
NZ (1)	NZ540496A (xx)
PE (1)	PE20040770A1 (xx)
PL (1)	PL377110A1 (xx)
RS (1)	RS20050420A (xx)
RU (1)	RU2005121909A (xx)
TW (1)	TW200503707A (xx)
WO (1)	WO2004062652A1 (xx)
ZA (1)	ZA200504656B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7521481B2 (en)	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
NZ546887A (en)	2003-11-03	2009-04-30	Probiodrug Ag	Combinations useful for the treatment of neuronal disorders
EP1713780B1 (en)	2004-02-05	2012-01-18	Probiodrug AG	Novel inhibitors of glutaminyl cyclase
EP1812007B1 (en)	2004-11-02	2011-09-07	Northwestern University	Pyridazine compounds and methods
US8158627B2 (en)	2006-04-28	2012-04-17	Northwestern University	Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
AR066664A1 (es) *	2007-05-22	2009-09-02	Otsuka Pharma Co Ltd	Un medicamento para tratar enfermedad de alzheimer
BR112014010228B1 (pt) *	2011-10-28	2020-09-29	Lumena Pharmaceuticals Llc	Uso de inibidores de reciclagem de ácido biliar para o tratamento de hipercolemia e doença hepática colestática
EA201891154A1 (ru)	2011-10-28	2019-02-28	ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи	Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2040996A1 (en) *	1990-05-02	1991-11-03	Robert L. Albright	Composition and method for controlling cholesterol
CA2104594C (en) *	1991-02-22	2004-05-11	Howard K. Shapiro	Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
US6383500B1 (en) *	1996-06-27	2002-05-07	Washington University	Particles comprising amphiphilic copolymers, having a crosslinked shell domain and an interior core domain, useful for pharmaceutical and other applications
US5985936A (en) *	1997-12-18	1999-11-16	Forbes Medi-Tech, Inc.	Method of preventing and delaying onset of Alzheimer's disease and composition therefor
ES2257824T3 (es) *	1998-01-28	2006-08-01	Warner-Lambert Company Llc	Metodo para tratar la enfermedad de alzheimer.
US6080778A (en) *	1998-03-23	2000-06-27	Children's Medical Center Corporation	Methods for decreasing beta amyloid protein
US6221897B1 (en) *	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19825804C2 (de) *	1998-06-10	2000-08-24	Aventis Pharma Gmbh	1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19845405C2 (de) *	1998-10-02	2000-07-13	Aventis Pharma Gmbh	Arylsubstituierte Propanolaminderivate und deren Verwendung
US20010028895A1 (en) *	2000-02-04	2001-10-11	Bisgaier Charles L.	Methods of treating alzheimer's disease
US20020028826A1 (en) *	2000-06-15	2002-03-07	Robl Jeffrey A.	HMG-CoA reductase inhibitors and method
SE0104334D0 (sv) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
TWI329111B (en) *	2002-05-24	2010-08-21	X Ceptor Therapeutics Inc	Azepinoindole and pyridoindole derivatives as pharmaceutical agents

2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/fr not_active Expired - Fee Related
2003
- 2003-12-10 EP EP03815109A patent/EP1572174A1/fr not_active Withdrawn
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/es not_active Application Discontinuation
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/ko not_active Application Discontinuation
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/ja not_active Abandoned
- 2003-12-10 AR ARP030104540A patent/AR042354A1/es not_active Application Discontinuation
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/zh active Pending
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/pt not_active IP Right Cessation
- 2003-12-10 CA CA002507945A patent/CA2507945A1/fr not_active Abandoned
- 2003-12-10 PL PL377110A patent/PL377110A1/pl not_active Application Discontinuation
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/sr unknown
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/ru not_active Application Discontinuation
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/es not_active Application Discontinuation
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/fr active Application Filing
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-11 TW TW092134949A patent/TW200503707A/zh unknown
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/es not_active Application Discontinuation
- 2005-06-10 HR HR20050534A patent/HRP20050534A2/xx not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/fr unknown
- 2005-07-08 NO NO20053341A patent/NO20053341L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20053341L (no)	2005-09-07
KR20050084250A (ko)	2005-08-26
MXPA05005556A (es)	2005-07-26
PL377110A1 (pl)	2006-01-23
AU2003296802A1 (en)	2004-08-10
RU2005121909A (ru)	2006-01-20
CN1726016A (zh)	2006-01-25
HRP20050534A2 (en)	2006-11-30
WO2004062652A1 (fr)	2004-07-29
ZA200504656B (en)	2006-08-30
NO20053341D0 (no)	2005-07-08
JP2006514063A (ja)	2006-04-27
FR2848452B1 (fr)	2007-04-06
FR2848452A1 (fr)	2004-06-18
TW200503707A (en)	2005-02-01
NZ540496A (en)	2008-04-30
CO5700712A2 (es)	2006-11-30
BR0317280A (pt)	2005-11-08
CA2507945A1 (fr)	2004-07-29
PE20040770A1 (es)	2004-12-10
AR042354A1 (es)	2005-06-15
MA27500A1 (fr)	2005-08-01
EP1572174A1 (fr)	2005-09-14

Publication	Publication Date	Title
PT1509232E (pt)	2009-01-07	Uma combinação de um antagonista de nmda e inibidores da acetilcolina esterase para o tratamento da doença de alzheimer
GB0223040D0 (en)	2002-11-13	Therapeutic compounds
MXPA01006472A (es)	2004-03-10	Combinaciones de inhibidores de transporte de acido biliar ileal y derivados de acido fibrico para indicaciones cardiovasculares.
IL160065A0 (en)	2004-06-20	17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AP2004003189A0 (en)	2004-12-31	Use of CETP inhibitors and optionally HMG COA reductase inhibitors and/or antihypertensive agents.
EP1578414A4 (en)	2007-10-24	PHENYLALANINE DERIVATIVES ALSDIPEPTIDYL-PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
WO2000061167A3 (en)	2001-01-11	TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-λB ACTIVITY INHIBITORS
EP1638950A4 (en)	2010-06-30	CYCLOHEXYLGLYCIN DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES
MY121399A (en)	2006-01-28	Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
SI1663185T1 (sl)	2009-04-30	Preprečevanje in zdravljenje z vnetjem inducirane in/ali imunsko posredovane izgube kosti
ZA200410011B (en)	2006-07-26	Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
AP2004002951A0 (en)	2004-03-31	"Combination of Eplerenone and an HMG CoA Reductase Inhibitor".
AU2004208615B2 (en)	2007-05-03	Medicine for prevention of and treatment for arteriosclerosis and hypertension
PL377344A1 (pl)	2006-01-23	Lekarstwo do profilaktyki i leczenia miażdżycy tętnic i nadciśnienia
IL174536A0 (en)	2008-04-13	Therapeutic treatment
EA200702212A1 (ru)	2008-04-28	Способ лечения или профилактики разрушения кости или остеопороза
AU2003231252A1 (en)	2003-11-11	Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
WO2004043456A8 (en)	2004-07-22	Cholesterol absorption inhibitors for the treatment of demyelination
MXPA05009986A (es)	2005-11-04	Tratamiento de la enfermedad de alzheimer.
RS20050420A (xx)	2007-04-10	Prevencija i lečenje alzheimer-ove bolesti
AU2003263760A1 (en)	2004-01-19	Methods for the treatment or prevention of obesity
AU2003290799A1 (en)	2004-06-15	17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
TW200714280A (en)	2007-04-16	Novel method of treating hyperlipidemia
WO2001037876A3 (en)	2002-03-21	Methods of ameliorating abnormal bone states
HK1080408A1 (en)	2006-04-28	Use of brimonidine in the treatment of dementia a nd parkinson